CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Net Income Growth by Quarter and Year

Atara Biotherapeutics,'s Net Income results by quarter and year



Select the Comparisons : Select the Ratio:                        

ATRA Net Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -35.31 -18.24 -21.25
III Quarter September - -31.10 -25.37 -11.87
II Quarter June - -27.43 -18.88 -14.95
I Quarter March -41.44 -25.65 -16.56 -9.16
FY   -41.44 -119.49 -79.05 -57.23



ATRA Net Income first quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the first quarter recorded net loss of $ -41.44 millions.

According to the results reported in the first quarter, Atara Biotherapeutics, Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Net Income no change of % ranks overall at the positon no. in the first quarter.




ATRA Net Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s first quarter 2018 Net Income $ -41.44 millions ATRA's Income Statement
Atara Biotherapeutics,'s first quarter 2017 Net Income $ -25.65 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Net Income Growth >>


ATRA Net Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Atara Biotherapeutics,'s Q/Q Net Income Growth


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's I. Quarter Q/Q Net Income Comment
Current accomplishment of -41.44 millions by Atara Biotherapeutics, Inc. appear even more unfavourable compare to the net loss -35.31 millions a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Net Income growth. While Atara Biotherapeutics,'s Net Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Net Income 12 Months Ending $ -135.28 $ -119.49 $ -102.41 $ -96.69 $ -88.14
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months net loss of $ -135 millions in the Mar 31 2018 period.
The situation is detiriorating as the cumulative net loss is inflating from $ -119.49 millions for the period from Dec 31 2017 to Mar 31 2017 and $ -35.31 millions for the twelve months ending in the quarter a year ago Dominic Evans wrote.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ATRA's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ATRA's Competitors
Net Income Growth for Atara Biotherapeutics,'s Suppliers
Net Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2018
Ani Pharmaceuticals Inc  95.31 %$ 95.313 millions
Regeneron Pharmaceuticals Inc  92.01 %$ 92.013 millions
Select Medical Holdings Corp  87.45 %$ 87.453 millions
Inogen Inc  81.36 %$ 81.355 millions
Innoviva, Inc.  80.05 %$ 80.053 millions
Pacific Health Care Organization Inc  79.83 %$ 79.828 millions
Amedisys Inc  79.75 %$ 79.749 millions
Teva Pharmaceutical Industries Ltd  76.91 %$ 76.911 millions
Medpace Holdings, Inc.  72.26 %$ 72.262 millions
Integra Lifesciences Holdings Corp  71.91 %$ 71.911 millions
U S Physical Therapy Inc  66.62 %$ 66.622 millions
Hca Healthcare, Inc.  64.99 %$ 64.994 millions
Abbvie Inc.  62.65 %$ 62.653 millions
Intuitive Surgical Inc  59.79 %$ 59.789 millions
Halyard Health, Inc.  57.81 %$ 57.813 millions
Biogen Inc.  56.68 %$ 56.682 millions
Pra Health Sciences, Inc.  55.47 %$ 55.467 millions
Capstone Therapeutics Corp.  51.68 %$ 51.680 millions
Chemed Corp  50.77 %$ 50.771 millions
Shire Plc  46.83 %$ 46.827 millions
Alexion Pharmaceuticals Inc  46.53 %$ 46.529 millions
Luminex Corp  45.64 %$ 45.639 millions
Neurometrix, Inc.  44.11 %$ 44.109 millions
Baxter International Inc  43.01 %$ 43.015 millions
Tivity Health, Inc.  39.81 %$ 39.807 millions
Integrated Biopharma Inc  39.31 %$ 39.308 millions
Align Technology Inc  38.10 %$ 38.096 millions
United Therapeutics Corp  36.90 %$ 36.898 millions
Dentsply Sirona Inc.  35.85 %$ 35.846 millions
Mylan N.v.  31.17 %$ 31.175 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TGLO's Profile

Stock Price

TGLO's Financials

Business Description

Fundamentals

Charts & Quotes

TGLO's News

Suppliers

TGLO's Competitors

Customers & Markets

Economic Indicators

TGLO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071